COTININE

The COTININE test measures cotinine, the primary metabolite of nicotine, in biological samples (urine, saliva, or blood) to provide an objective assessment of recent nicotine exposure. It detects both active smoking and passive (secondhand) smoke exposure and is useful for monitoring smoking-cessation progress, prenatal exposure assessment, or workplace/clinical verification. Home sample collection is available across Dubai through UAE-certified laboratories, ensuring secure transport and professional handling.

• Urinary cotinine concentration
• Salivary cotinine concentration
• Serum/plasma cotinine concentration
• Creatinine-adjusted urinary cotinine

• Monitoring progress during a smoking-cessation program
• Confirming abstinence before medical procedures or treatments
• Assessing secondhand smoke exposure in children or pregnant individuals
• Occupational or clinical screening for recent nicotine exposure
• Pre-employment or insurance-related nicotine verification (when requested)

• Objective, laboratory-quantified measure of recent nicotine exposure
• Supports clinicians and cessation coaches with reliable monitoring data
• Convenient home sample collection by UAE-certified lab teams across Dubai
• Sensitive detection of both active smoking and passive exposure
• Fast reporting to aid timely clinical or behavioural interventions

• Sample type: urine, saliva, or blood (collected per lab instructions)
• No fasting required; avoid nicotine products or nicotine replacement 24–72 hours before testing if verifying abstinence
• Home collection available across Dubai—provide valid Emirates ID or passport and informed consent (parent/guardian for minors)
• Allow standard laboratory turnaround time; lab will advise exact timing and reporting in AED-relevant booking confirmation